These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 31413581)
1. The clinical significance of statins-macrolides interaction: comprehensive review of in vivo studies, case reports, and population studies. Abu Mellal A; Hussain N; Said AS Ther Clin Risk Manag; 2019; 15():921-936. PubMed ID: 31413581 [TBL] [Abstract][Full Text] [Related]
9. Statin safety and drug interactions: clinical implications. Bottorff MB Am J Cardiol; 2006 Apr; 97(8A):27C-31C. PubMed ID: 16581325 [TBL] [Abstract][Full Text] [Related]
10. A population-based analysis of the risk of drug interaction between clarithromycin and statins for hospitalisation or death. Mesgarpour B; Gouya G; Herkner H; Reichardt B; Wolzt M Lipids Health Dis; 2015 Oct; 14():131. PubMed ID: 26497728 [TBL] [Abstract][Full Text] [Related]
11. Co-administration of statins with cytochrome P450 3A4 inhibitors in a UK primary care population. Bakhai A; Rigney U; Hollis S; Emmas C Pharmacoepidemiol Drug Saf; 2012 May; 21(5):485-93. PubMed ID: 22237927 [TBL] [Abstract][Full Text] [Related]
12. Incidence of potential drug interactions in co-prescription of statins and macrolide antibiotics in Croatia during the 14 year period. Grgurević D; Grgurević J; Vrca VB; Marušić S; Marinović I; Grgurević AB Pharmazie; 2021 Jun; 76(6):272-278. PubMed ID: 34078522 [TBL] [Abstract][Full Text] [Related]
13. Concomitant use of statins and CYP3A4 inhibitors in administrative claims and electronic medical records databases. Ming EE; Davidson MH; Gandhi SK; Marotti M; Miles CG; Ke X; McKenney JM J Clin Lipidol; 2008 Dec; 2(6):453-63. PubMed ID: 21291779 [TBL] [Abstract][Full Text] [Related]
14. Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance. Neuvonen PJ; Niemi M; Backman JT Clin Pharmacol Ther; 2006 Dec; 80(6):565-81. PubMed ID: 17178259 [TBL] [Abstract][Full Text] [Related]
15. Statin-associated incident diabetes: a literature review. Park ZH; Juska A; Dyakov D; Patel RV Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689 [TBL] [Abstract][Full Text] [Related]
16. Statin safety: a systematic review. Law M; Rudnicka AR Am J Cardiol; 2006 Apr; 97(8A):52C-60C. PubMed ID: 16581329 [TBL] [Abstract][Full Text] [Related]
17. Concomitant use of statins and macrolide antibiotics and risk of serious renal events: A nationwide cohort study. Lund M; Svanström H; Pasternak B; Hviid A; Melbye M Int J Cardiol; 2018 Oct; 269():310-316. PubMed ID: 30072148 [TBL] [Abstract][Full Text] [Related]
18. Assessment of ADRs associated with lipid-lowering agents recorded in the Department of Internal Medicine, University Hospital, Jena. Hippius M; Farker K; Helble S; Hoffmann A Int J Clin Pharmacol Ther; 2002 Mar; 40(3):97-101. PubMed ID: 11911604 [TBL] [Abstract][Full Text] [Related]
19. Safety of lovastatin/extended release niacin compared with lovastatin alone, atorvastatin alone, pravastatin alone, and simvastatin alone (from the United States Food and Drug Administration adverse event reporting system). Alsheikh-Ali AA; Karas RH Am J Cardiol; 2007 Feb; 99(3):379-81. PubMed ID: 17261402 [TBL] [Abstract][Full Text] [Related]
20. Risk of adverse events among older adults following co-prescription of clarithromycin and statins not metabolized by cytochrome P450 3A4. Li DQ; Kim R; McArthur E; Fleet JL; Bailey DG; Juurlink D; Shariff SZ; Gomes T; Mamdani M; Gandhi S; Dixon S; Garg AX CMAJ; 2015 Feb; 187(3):174-180. PubMed ID: 25534598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]